BASSO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.889
EU - Europa 2.774
AS - Asia 1.887
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 12
SA - Sud America 8
AF - Africa 3
Totale 27.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.860
CN - Cina 1.530
FI - Finlandia 657
IT - Italia 565
SE - Svezia 495
DE - Germania 394
UA - Ucraina 275
GB - Regno Unito 190
VN - Vietnam 179
IE - Irlanda 46
IN - India 45
FR - Francia 37
KR - Corea 35
NL - Olanda 29
EU - Europa 26
CA - Canada 25
HK - Hong Kong 25
RU - Federazione Russa 25
JP - Giappone 19
RO - Romania 17
ES - Italia 10
GR - Grecia 9
IL - Israele 8
IR - Iran 8
TR - Turchia 8
AU - Australia 7
SI - Slovenia 7
ID - Indonesia 5
NZ - Nuova Zelanda 5
SG - Singapore 5
BR - Brasile 4
MX - Messico 4
PH - Filippine 4
PL - Polonia 4
HR - Croazia 3
IQ - Iraq 3
BE - Belgio 2
CL - Cile 2
EG - Egitto 2
GE - Georgia 2
KG - Kirghizistan 2
NO - Norvegia 2
OM - Oman 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PT - Portogallo 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 27.599
Salva come PNG Salva come JPEG
Città #
Fairfield 3.350
Woodbridge 2.596
Houston 2.125
Ann Arbor 2.077
Chandler 1.923
Ashburn 1.542
Wilmington 1.266
Jacksonville 1.220
Cambridge 1.212
Seattle 1.104
Princeton 565
Medford 375
Beijing 373
Des Moines 368
San Diego 340
Nanjing 286
Helsinki 249
Roxbury 218
Padova 211
Boardman 192
Dong Ket 179
Guangzhou 99
Nanchang 85
Shenyang 82
Hebei 72
Changsha 65
Jiaxing 59
New York 57
Tianjin 56
Jinan 55
Norwalk 51
Milan 44
Dublin 40
Shanghai 39
Redwood City 37
London 34
Zhengzhou 32
Kharkiv 29
Los Angeles 29
Ogden 25
Hong Kong 24
Indiana 21
Kilburn 20
Gangdong-gu 19
Pune 19
Washington 19
Borås 18
Detroit 18
Rome 17
Hefei 16
Haikou 15
Kunming 15
Taizhou 15
Ningbo 12
Nowon-gu 12
Hangzhou 11
Bologna 10
Chicago 10
Falls Church 10
Lanzhou 10
Nürnberg 10
Rockville 10
Phoenix 9
Yellow Springs 9
Casier 8
Fuzhou 8
Hounslow 8
Lappeenranta 8
Limena 8
Paris 8
San Francisco 8
Taiyuan 8
Orange 7
Amsterdam 6
Indianapolis 6
Legnaro 6
Montreal 6
Munich 6
Tappahannock 6
Turin 6
Aprilia 5
Auburn Hills 5
Mestre 5
Ramat Gan 5
Tokyo 5
Verona 5
Vicenza 5
Wandsworth 5
Wuhan 5
Ancaster 4
Ferrara 4
Hanover 4
Leawood 4
Linköping 4
Melbourne 4
Naperville 4
New Bedfont 4
Pinehaven 4
Radoslaw 4
Salerno 4
Totale 23.312
Salva come PNG Salva come JPEG
Nome #
A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies 193
Is Vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 182
Diagnostic testing for celiac disease 176
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 172
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 172
Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial 158
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 154
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 154
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 141
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 138
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 138
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 137
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 136
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 136
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension 136
Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting 135
Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma. 132
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 128
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes 127
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 125
Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis. 125
Lack of association for reported endocrine pancreatic cancer risk Loci in the PANDoRA consortium 124
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 124
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 122
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 121
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 120
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 120
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 120
Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? 118
Celiac disease in North Italian patients with autoimmune Addison's disease. 118
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination. 115
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 115
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 113
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 113
Serum deoxyribonuclease and ribonuclease in pancreatic cancer and chronic pancreatitis. 110
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 109
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 108
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? 108
Does serum HPP in chronic pancreatic diseases indicate exocrine pancreatic dysfunction and damage ?. 106
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors? 106
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 106
Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. 105
Concanavalin A affinity pattern of CA 19-9: an in vitro and in vivo study. 105
DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis 105
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 105
Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen determination. 104
Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma 104
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA. 104
Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide 103
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload 103
Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma 102
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 101
Serum pepsinogen C: a useful marker of Helicobacter pylori eradication? 101
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 101
Pathogenesis of Helicobacter pylori in humans. 101
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 100
The circulating miRNAs as diagnostic and prognostic markers 100
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 100
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 99
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 99
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 98
H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome 98
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 98
Celiac disease and type 1 diabetes 97
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 97
Acute reflux pancreatitis in rats: A comparison between two experimental models 97
Addison's disease: a survey on 633 patients in Padova. 97
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 97
Biliary hyperpressure in rat extrahepatic cholestasis alters horseradish peroxidase biliary excretion. 96
Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives. 95
Does acetylsalicylic acid interfere with stimulated pancreatic secretion? An experimental study in the rat. 94
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 94
Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis 94
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 94
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 93
A preliminary fastview of mitochondrial protein profile from healthy and type 2 diabetic subjects. 93
Immunotherapy for gastric premalignant lesions and cancer. 93
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism? 93
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 92
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 92
GastroPanel: Evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. 92
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 92
CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. 91
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 91
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 91
Non-invasive assessment of chronic liver and gastric diseases. 90
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 90
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 90
Pathogenesis of Helicobacter pylori infection. 90
Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern 89
FAILURE OF SECRETIN TO EXERT AN AMELIORATIVE EFFECT ON ACUTE REFLUX PANCREATITIS IN THE RAT 88
Inflammatory bowel diseases: from pathogenesis to laboratory testing 88
Serum deoxyribonuclease and ribonuclease in pancreatic cancer and chronic pancreatitis 88
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 88
Efficacy of zinc supplementation in preventing acute hepatitis in Long-Evans Cinnamon rats 88
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. 86
Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer 86
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer 86
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma 85
Insights in the laboratory diagnosis of celiac disease 84
Totale 11.008
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.580
article - articoli 64.554
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 300
Totale 155.434
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.488 0 0 0 0 0 0 0 0 0 0 758 730
2019/20205.367 867 164 80 397 539 482 438 580 547 675 351 247
2020/20214.254 196 370 275 418 186 315 147 366 529 548 431 473
2021/20224.573 92 753 418 248 179 371 204 398 213 97 457 1.143
2022/20234.330 894 440 55 438 778 634 25 247 522 38 182 77
2023/20241.848 95 300 244 174 165 275 228 147 95 125 0 0
Totale 27.865